Results 311 to 320 of about 144,594 (359)

Profunda femoris-popliteal shunt. Medical approach.

Minnesota medicine, 1966
H H, Farley, R L, Telander, C R, Hitchcock   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transjugular Intrahepatic Portosystemic Shunt: A Medical Perspective

Digestive Diseases, 1995
The transjugular intrahepatic portosystemic shunt (TIPS) is an exciting new addition to the therapeutic armamentarium against portal hypertension. It is currently indicated for salvage of patients with active variceal hemorrhage despite sclerotherapy or where sclerotherapy is not feasible.
Mitchell L. Shiffman, Arun J. Sanyal
openaire   +3 more sources

Treatment of Cerebrospinal Fluid Shunt Infections with Medical Therapy Alone

Neurosurgery, 1982
Abstract Eight of 48 patients with shunt infections were treated with antibiotic therapy only. Seven of the 8 were cured and remained infection-free for at least 1 year. Six of the 7 patients had developed infection within 2 weeks of shunt insertion or revision.
K Shapiro, J Glaser, S Mates
openaire   +3 more sources

Medication overuse as a cause of chronic headache in shunted hydrocephalus patients

Journal of Neurology, Neurosurgery & Psychiatry, 2010
To highlight the group of hydrocephalus patients known to have a long history of shunt revisions and refractory chronic headache. When a shunt in perfect working order has no effect on headache, other causes of headache should be investigated. In this paper, patients with medication overuse headache are identified and the positive effect of medication ...
Willer, Lasse, Jensen, R H, Juhler, M
openaire   +4 more sources

Medical management of congenital portosystemic shunts in 27 dogs—a retrospective study

Journal of Small Animal Practice, 1998
Case records of 27 dogs with medically managed congenital portosystemic shunts were reviewed. Fourteen were followed up by telephone questionnaires to the owners. Age, breed, sex, clinical signs and blood results were similar to previous studies. Weight and quality of life were stable or improved on treatment in all cases.
Michael E. Herrtage, Penny Watson
openaire   +2 more sources

Medical and socioeconomic predictors of quality of life in myelomeningocele patients with shunted hydrocephalus

Child's Nervous System, 2017
Children with myelomeningocele (MMC) often develop hydrocephalus, and the combination of these conditions can lead to psychosocial, cognitive, and physical health issues that decrease their health-related quality of life (HRQOL). The goal of the present study was to understand the QOL in patients with MMC and shunted hydrocephalus.Data from the Toronto
Abhaya V. Kulkarni, Brij S Karmur
openaire   +2 more sources

Lumboperitoneal shunt in a patient with Behçet’s disease with medically refractory intracranial hypertension

Journal of Clinical Neuroscience, 2011
A 21-year-old male presented with severe throbbing headache, nausea, vomiting and progressive visual loss. Clinical examination revealed bilateral papilledema and left abducens nerve palsy. MRI showed findings consistent with dural sinus thrombosis. Combinging the clinical findings, MRI and a positive pathergy test, the patient was diagnosed with dural
Yalcin Kocaogullar, Emine Genç, Banu Ozturk, Betigul Yuruten, Gulce Unal Yıldız, Ebru Apaydın Doğan, Muzaffer Mutluer   +6 more
openaire   +3 more sources

Do P‐glycoprotein Medications Alter the Risk of Ventriculoperitoneal Shunt in Adults with Hydrocephalus?

The Journal of Clinical Pharmacology, 2023
AbstractHydrocephalus is a disorder caused by excess fluid accumulation in the brain and results in brain damage with consequent cognitive and physical problems. This condition has no cure; the only treatment is brain surgery. Experimental data indicate that P‐glycoprotein (P‐gp) plays a crucial role in the pathogenesis of hydrocephalus due to its ...
Jason R. Grullon, George W. Koutsouras, Nneka F. Onwumere, David F. Lehmann, Satish Krishnamurthy   +4 more
openaire   +2 more sources